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Abstract 
The immunopurification of the endogenous cytoplasmic murine histone deacetylase 
6 (mHDAC6), a member of the class II HDACs,
 
from mouse testis cytosolic extracts allowed 
the identification
 
of two associated proteins. Both were mammalian homologues of
 
yeast 
proteins known to interact with each other and involved
 
in the ubiquitin signaling pathway: 
p97/VCP/Cdc48p, a homologue
 
of yeast Cdc48p, and phospholipase A2-activating protein, a 
homologue
 
of yeast UFD3 (ubiquitin fusion degradation protein 3). Moreover,
 
in the C-
terminal region of mHDAC6, a conserved zinc finger-containing
 
domain named ZnF-UBP, 
also present in several ubiquitin-specific
 
proteases, was discovered and was shown to mediate 
the specific
 
binding of ubiquitin by mHDAC6. By using a ubiquitin pull-down
 
approach, nine 
major ubiquitin-binding proteins were identified
 
in mouse testis cytosolic extracts, and 
mHDAC6 was found to be
 
one of them. All of these findings strongly suggest that mHDAC6
 
could be involved in the control of protein ubiquitination. The
 
investigation of biochemical 
properties of the mHDAC6 complex
 
in vitro further supported this hypothesis and clearly 
established
 
a link between protein acetylation and protein
 
ubiquitination.  
 
 
Introduction 
 An increasing number of histone deacetylases (HDACs) are being characterized in 
higher eukaryotes. These proteins have been
 
grouped in distinct families according to the 
similarity of their
 
sequence to a yeast founding member. Class I HDACs are homologous
 
to 
yeast RPD3, while class II members are related to yeast HDA1
 
and class III members are 
related to yeast SIR2 deacetylase (13,
 
20). Class I HDACs are found in various nuclear 
multiprotein
 
complexes containing either HDAC1/2 or HDAC3. Class II HDACs show
 
the 
interesting property of being capable of a nucleocytoplasmic
 
shuttling. Indeed, all of the class 
II HDACs, HDAC4, -5, -6, and
 
-7, are subject to a regulated intracellular localization (20).
 
Although there is evidence for a role for some of these HDACs
 
in transcriptional repression, 
their possible function in the
 
cytoplasm remains elusive (20, 21). Within these enzymes,
 
the 
endogenous HDAC6 was found to be essentially cytoplasmic (2,
 
37). A fraction of the murine 
HDAC6 (mHDAC6) translocates, however,
 
in the nucleus under specific circumstances, such 
as arrest of
 
cell proliferation (37). In order to gain an insight into the
 
function of cytoplasmic 
HDACs, cytosolic mHDAC6 was immunopurified
 
from mouse testis cytosolic extracts. The 
identified mHDAC6-associated
 
proteins showed striking sequence homology to yeast 
regulatory
 
proteins involved in the control of protein ubiquitination. These
 
proteins are the 
mammalian homologue of yeast UFD3, known as phospholipase
 
A2-activating protein 
(PLAP) (12), as well as the homologue
 
of yeast Cdc48p AAA ATPase (p97/VCP/Cdc48p) 
(11). The UFD pathway
 
was discovered in yeast after the observation that a protein containing
 
a nonremovable N-terminal ubiquitin (Ub) moiety had a short half-life
 
(19). The protein 
degradation pathway involved was called UFD,
 
for Ub fusion degradation. A genetic 
approach was used to dissect
 
this pathway, and five genes termed UFD1 to UFD5 were 
discovered
 
to be involved in the degradation of the substrate in vivo (12,
 
19). Evidence of the 
role of some of these proteins in Ub-dependent
 
degradation of target substrates was later 
discovered. For instance,
 
UFD2 (also known as E4) was shown to bind to Ub moieties of 
preformed
 
conjugates and catalyze Ub chain assembly (22). UFD5 is a transcription
 
factor 
regulating genes encoding proteosomal subunits (38).
 
Interestingly, Cdc48p was shown to 
interact with both UFD2 (22)
 
and UFD3 (12), but its role in the function of these UFD 
proteins
 
has remained
 
unclear.  
 In mammals, several proteins showing striking sequence homology with these yeast 
UFD proteins have been discovered. A mammalian
 
homologue of yeast UFD1 has recently 
been identified and was shown
 
to form a specific complex with the mammalian homologue of 
yeast
 
Cdc48p, p97/VCP/Cdc48 (27). The gene encoding the mammalian
 
homologue of UFD2 
has been shown to fuse with another gene (named
 
D4Cole1e) in the slow Wallerian 
degeneration mutant mouse (8).
 
The chimeric mRNA is abundantly expressed in the nervous 
system
 
and encodes a fusion protein containing the 40 N-terminal amino-acid
 
region of UFD2. 
The homologue of UFD3 in mammals is PLAP (reference
 
12 and reported here) which seems 
to participate in the control
 
of the cellular levels of prostaglandin and the activity of 
phospholipase
 
A2 and phospholipases C and D (30). UFD4 is homologous to E6AP
 
(19), a 
human protein possessing a Ub-ligase activity (34),
 
interacting with the papillomavirus-
encoded oncogene E6 and involved
 
in the Ub-dependent degradation of p53 (17, 18).  
The mammalian homologues of yeast UFD proteins therefore appear to be involved in a 
variety of functions. Here we show that
 
one of them, the mammalian homologue of UFD3, is 
a member of the
 
cytoplasmic mHDAC6 complex. It is also shown here that mHDAC6
 
can 
specifically interact with Ub and that the Ub-bound mHDAC6
 
maintains its deacetylase 
activity. Moreover p97/VCP/Cdc48, interacting
 
with UFD proteins in yeast as well as in 
mammals, was also found
 
in the mHDAC6 complex. That mHDAC6 is one of the major 
cytoplasmic
 
Ub-binding proteins present in mouse testis cytosolic extracts
 
and that most of the 
Ub-binding proteins identified in this work
 
were involved in the Ub/proteasome-dependent 
regulatory pathways
 
strongly suggest that the deacetylase mHDAC6 is also involved
 
in the Ub 
signaling pathway. This conclusion was further supported
 
by in vitro experiments with mouse 
testis cytosolic
 
extracts. 
 
 
Materials and Methods 
Fractionation of spermatogenic cells. Spermatogenic cells of all stages were recovered from 
the testes of an adult mouse. Cell suspensions enriched in mouse spermatogenic
 
cells at 
specific stages of their differentiation, were obtained
 
by velocity sedimentation at unit gravity 
on a bovine serum albumin
 
(BSA) gradient, according to a method described previously (4,
 
31). This technique allows germ cells to be separated according
 
to their respective sizes and
 
densities.  
Cell fractionation and Western blotting. Western blot analysis was performed by standard 
procedures. Cytoplasmic and nuclear extracts were obtained as follows. Cells
 
were lysed in 
buffer D (15 mM NaCl, 60 mM KCl, 12% sucrose, 2
 
mM EDTA, 0.5 mM EGTA, 0.65 mM 
spermidine, 1 mM dithiothreitol
 
[DTT], 0.5 mM phenylmethylsulfonyl fluoride [PMSF], 
0.05% Triton
 
X-100). Nuclei were pelleted by centrifugation, and the supernatant
 
(cytoplasmic extract) was kept at 80°C. Nuclei were resuspended
 
in a small volume of 
buffer D and layered over 11 ml of the same
 
buffer and centrifuged at 1,000 × g for 5 min. 
The pellet was
 
lysed directly in protein loading buffer and homogenized by
 
sonication.  
Large-scale purification of mHDAC6 and associated proteins. Mouse testes were isolated, 
sliced, and homogenized in an ice-cold lysis buffer (500 µl/testis) containing 0.34 M sucrose,
 
60 mM KCl, 15 mM NaCl, 15 mM Tris-HCl (pH 7.4), 0.65 mM spermidine,
 
2 mM EDTA, 
0.5 mM EGTA, 0.05% Triton X-100, 1 mM DTT, 0.5 mM PMSF.
 
The homogenate was 
incubated for 30 min on ice and centrifuged
 
at 16,000 × g for 30 min at 4°C. The supernatant 
was recovered
 
and centrifuged for 1 h at 100,000 × g, at 4°C (cytoplasmic extract).
 
Anti-
mHDAC6 antibody (37) or peptide-blocked anti-mHDAC6 antibody
 
(antibody preincubated 
for 30 min at 4°C with its target peptide)
 
was incubated with the extract at 4°C for 1 h. 
Immunocomplexes
 
were precipitated with protein G-Sepharose, washed three times
 
in lysis 
buffer, and eluted by the target peptide (1 mg/ml) at
 
4°C
 
overnight.  
Mass spectrometry and protein identification. After separation by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), the protein bands were excised from
 
the 
Coomassie blue-stained gel and washed with 50% acetonitrile
 
and 25 mM NH
4
HCO
3
. Gel 
pieces were dried in a vacuum centrifuge
 
and reswollen in 20 µl of 25 mM NH
4
HCO
3
 
containing 0.5 µg of trypsin
 
(Promega, sequencing grade). After a 4-h incubation at 37°C, a
 
0.5-µl aliquot was removed for matrix-assisted laser desorption
 
ionization-time of flight 
(MALDI-TOF) analysis and spotted onto
 
the MALDI sample probe on top of a dried 0.5-µl 
mixture of a 4-volume
 
solution of saturated -cyano-4-hydroxy-trans-cinnamic acid in
 
acetone 
and 3 volumes of nitrocellulose (10 mg/ml) dissolved in
 
acetone-isopropanol (1:1 [vol/vol]). 
Samples were rinsed by placing
 
a 5-µl volume of 0.1% (vol/vol) trifluoroacetic acid (TFA) on
 
the matrix surface after the analyte solution had dried completely.
 
After 2 min, the liquid was 
blown off by pressurized air. MALDI
 
mass spectra of peptide mixtures were obtained by 
using a Bruker
 
Biflex mass spectrometer (Bruker-Franzen Analytik). Monoisotopic
 
peptide 
masses were assigned and used for database searching.
 
When no consistent hit was found, 
protein identification was achieved
 
by tandem mass spectrometry (MS/MS) analysis. After in-
gel tryptic
 
digestion, the gel pieces were extracted with 5% (vol/vol) formic
 
acid solution and 
then with acetonitrile. The extracts were combined
 
with the original digest, and the sample 
was evaporated to dryness
 
in a vacuum centrifuge. The residues were dissolved in 0.1% 
(vol/vol)
 
formic acid and desalted with a Zip Tip (Millipore). Elution of
 
the peptides was 
performed with 5 to 10 µl of a 50:50:0.1 (vol/vol)
 
acetonitrile-H
2
O-formic acid solution. The 
peptide solution was
 
introduced into a glass capillary (Protana) for nanoelectrospray
 
ionization. MS/MS experiments were carried out on a Q-TOF hybrid
 
mass spectrometer 
(Micromass) in order to obtain sequence information.
 
Collision-induced dissociation (CID) of 
selected precursor ions
 
was performed with argon as the collision gas and with collision
 
energies of 40 to 60 eV. MS/MS sequence information was used for
 
database searching with 
the programs (i) MS-Edman located at the
 
University of California San Francisco (http: 
//prospector.ucsf.edu/),
 
(ii) BLAST located at the National Center for Biotechnology 
Information
 
(http://www.ncbi.nlm.nih.gov/BLAST/), and (iii) FASTS or TFASTS
 
located at 
the University of Virginia (http://fasta.bioch.virginia.edu
 
/fasta/cgi/).  
Ub-binding assays. Twenty-five microliters of extracts was diluted with 25 µl of buffer A 
containing 50 mM Tris-HCl (pH 7.5), 5 mM MgCl
2
, 2 mM
 
ATP, and 0.2 mM DTT. Ten 
microliters of 50% Ub-agarose matrix
 
(preincubated with 1 mg of BSA per ml) was added. 
After 1 h at
 
room temperature, Ub-agarose was pelleted and washed in buffer
 
A. Bound 
proteins were eluted and used for Western blot analysis.
 
Glutathione S-transferase (GST) pull-
downs were performed by the
 
same
 
protocol.  
Identification of cytoplasmic Ub-binding proteins (by Ub-agarose pull-down). Five 
hundred microliters of cytoplasmic extract from mouse testis was incubated with 500 µg of 
free Ub (10 µg/µl; Sigma) or
 
50 µl of buffer A containing 50 mM Tris-HCl (pH 7.5), 5 mM 
MgCl
2
,
 
2 mM ATP, and 0.2 mM DTT for 30 min at 4°C. The pull-down was
 
performed by 
addition of 200 µl of 50% Ub-agarose matrix (preincubated
 
with 1 mg of BSA per ml). After 
1 h at room temperature, Ub-agarose
 
was pelleted and washed three times with buffer 
A. Bound proteins
 
were eluted in buffer A containing free Ub. Eluted proteins were
 
concentrated and analyzed by SDS-PAGE and mass
 
spectrometry.  
In vitro ubiquitination reaction. Reactions were performed in a buffer containing 50 mM 
Tris-HCl (pH 7.5), 5 mM MgCl
2
, and 0.2 mM DTT in a total volume of 20
 
µl. Cytoplasmic 
extracts from mouse testis were incubated for
 
30 min at room temperature with various 
amounts of bacterially
 
expressed and purified His C-terminal mHDAC6 or the same fragment
 
from wild-type mHDAC6 or m2 mutant fused to GST or BSA. Ubiquitination
 
assay was 
performed by addition of 4 mM ATP and incubation for
 
1 h at room temperature. Reactions 
were stopped by addition of
 
SDS-PAGE sample buffer, and ubiquitinated proteins were 
analyzed
 
by SDS-PAGE and Western blotting with an antibody against
 
Ub.  
In situ immunodetection procedure. Anti-HDAC6 was a rabbit polyclonal antibody raised 
against a C-terminal peptide (37). For in situ immunofluorescence analysis,
 
cells were fixed in 
4% paraformaldehyde (PFA) in phosphate-buffered
 
saline (PBS) for 5 min at room 
temperature and permeabilized by
 
the addition of 0.1% Triton X-100. Incubation with primary 
antibodies
 
was carried out overnight at 4°C in the PBS-milk solution. After
 
the addition of the 
secondary antibodies, cells were washed and
 
counterstained with Hoechst 33258. The 
preparations were then
 
observed under an epifluorescence microscope (Zeiss Axiophot).
 
Numeric digital image acquisitions were realized with a cooled
 
charge-coupled device camera 
(C4880 Hamamatsu). Cryosections and
 
immunolocalization were performed as described 
before (6).  
Plasmid constructs. Vectors expressing hemagglutinin (HA)-tagged mHDAC1, -4, -5, or -
6 have been described previously (23). mHDAC6 deletion
 
mutants were obtained by PCR and 
substitution mutants by using
 
the QuickChange site-directed mutagenesis kit (Stratagene) and
 
controlled by sequencing. Human SUMO-1 and Ub cDNAs were cloned
 
in pGEX-5X3 vector 
(Pharmacia) after reverse transcription-PCR
 
(RT-PCR) amplification. The C-terminal Ub-
binding domain of the
 
mHDAC6 wild type or m2 mutant (amino acids 824 to 1149) was PCR
 
amplified and cloned in either the pET28b (Novagen) or pGEX-5X3
 
plasmid. The histidine-
tagged and GST fusion proteins were then
 
purified with, respectively, the Ni-nitrilotriacetic 
acid (NTA)
 
system (Qiagen) or gluthatione-Sepharose beads
 
(Pharmacia).  
Results 
 
mHDAC6 is predominantly expressed in spermatogenic cells. 
 
 The expression level of mHDAC6 was first examined in various mouse tissues in 
order to find the most appropriate tissue for
 
a large-scale purification of the endogenous 
protein. The use
 
of highly-specific anti-mHDAC6 antibody produced in our laboratory
 
(37) 
allowed us to show that mHDAC6 was predominantly expressed
 
in the testis (Fig. 1A). We 
then looked at whether mHDAC6 was
 
expressed in specific spermatogenic cell 
subpopulations and whether
 
it was localized, as observed earlier in somatic cells (37),
 
in the 
cell cytoplasm. For this purpose, spermatogenic cells were
 
fractionated with a sedimentation 
chamber into three fractions
 
enriched in pachytene spermatocytes (Fig. 1A, P), round 
spermatids
 
(Fig. 1A, RS), and a mixture of round and elongated spermatids
 
(Fig. 1A, ERS). 
We also prepared an extract from 6-day-old mice
 
testes, which are known to contain 
essentially spermatogonia and
 
Sertoli cells (3) (Fig. 1B, Gonia). Each of the cell populations
 
examined contained considerable amounts of mHDAC6 (Fig. 1A, fractions).
 
Moreover, as in 
tissue culture cells, mHDAC6 was localized predominantly
 
in the cytoplasm (Fig. 1B). This 
conclusion was confirmed afterwards
 
by in situ immunodetection of mHDAC6 on testis 
cryosections, in
 
which mHDAC6 was found in the cytoplasm of the majority of cells
 
(Fig. 
1C). One should keep in mind that, although mHDAC6 is overexpressed
 
in mouse testis, it is 
not encoded by a testis-specific gene,
 
since the presence of mHDAC6 mRNA in various 
mouse tissues (36)
 
was previously shown, as was the presence of the protein in four
 
unrelated 
murine cell lines (37).  
 
Immunopurification of mHDAC6-containing complex from testis cytosolic extracts.  
 
 The preferential accumulation of mHDAC6 in the cytoplasm of mouse spermatogenic 
cells prompted us to use a testis cytoplasmic
 
extract in order to immunoprecipitate mHDAC6 
and identify the
 
associated proteins. The immunopurified complex was eluted with
 
the target 
immunogenic peptide. As a control, the procedure of
 
immunopurification was carried out with 
an antibody preincubated
 
with an excess of the immunogenic target peptide. A fraction of
 
these immunoprecipitated materials (eluate from anti-mHDAC6 antibodies
 
or peptide-blocked 
antibodies) was used to run a gel, which was
 
then silver stained. Figure 2 clearly shows that 
mHDAC6 was very
 
efficiently immunopurified with our anti-mHDAC6 antibody, while
 
it was 
not with the same antibody blocked with the immunogenic
 
peptide. The identity of mHDAC6 
was confirmed by Western blot
 
analysis of the materials described above. Interestingly, two
 
bands, one migrating at 97 kDa and the other around 82 kDa, were
 
specifically 
coimmunoprecipitated with mHDAC6 and were not present
 
in eluate obtained from the 
peptide-blocked antibody. These proteins
 
were then isolated from a preparative gel and 
digested with trypsin,
 
and the fragments were analyzed by mass spectrometry. Comparison
 
with the predicted tryptic fragments of protein databases identified
 
one of these proteins as the 
mouse homologue of the yeast Cdc48p,
 
p97/VCP/Cdc48 (11). The other protein was PLAP. A 
database search
 
revealed that PLAP shows striking sequence homology to yeast UFD3
 
protein: 31 and 49% sequence identity and similarity, respectively,
 
to the yeast protein (12; 
data not shown). Interestingly, it
 
had been shown earlier in yeast that Cdc48p and UFD3 could 
form
 
a specific complex (12). Our findings added to these data suggest
 
that this interaction 
between Cdc48p and UFD3 would be conserved
 
during evolution and therefore have 
important functional significance.
 
Moreover, the interaction of mHDAC6 and 
p97/VCP/Cdc48 is not specific
 
to testis, since we also observed the presence of both proteins
 
in a complex in murine erythroleukemia cells by immunoprecipitating
 
p97/VCP/Cdc48 (data 
not shown).  
 
Sequence homology between several Ub-specific proteases and the C-terminal region of 
mHDAC6.  
 A search in the databank with the nondeacetylase regions of mHDAC6 showed a 
significant sequence homology between a limited
 
region of mHDAC6 located in its C-
terminal domain and particular
 
members of Ub-specific proteases (UBPs) from different 
species
 
(Fig. 3). Indeed, this region is cysteine and histidine rich,
 
and both PFAM and 
SMART protein prediction web servers (33)
 
identified it as the "ubiquitin carboxyl-terminal 
hydrolase-like
 
zinc finger" (ZnF-UBP) domain. Enzymes involved in the cleavage
 
of Ub fall 
into two families of cysteine proteases, UBPs and UCHs
 
(Ub C-terminal hydrolases). These 
enzymes are capable of interacting
 
with Ub, and in some of them, a domain known as UBA 
(Ub associated)
 
has been shown to mediate this interaction (5, 15). However,
 
since UBA is not 
present in all the UBPs and UCHs, we wondered
 
whether the ZnF-UBP domain could be 
another Ub-binding domain
 
present in UBA-less proteins. Accordingly, the Ub-binding 
activity
 
of the mHDAC6 ZnF-UBP domain was then investigated.  
 
mHDAC6 is a Ub-binding protein.  
 
 An extract from mouse testis was incubated with Ub-agarose, and a pull-down 
experiment was carried out. Figure 4A shows that
 
the endogenous mHDAC6, present in the 
extract, was able to interact
 
efficiently with Ub (lane 1). As a control, prior to the addition
 
of 
the Ub-agarose, the extract was incubated with increasing amounts
 
of free Ub (lanes 2 to 4) or 
BSA (lanes 5 to 7). The addition
 
of free Ub abolished the binding of mHDAC6 to the Ub-
agarose matrix,
 
while the addition of the same number of BSA molecules had no
 
effect on the 
mHDAC6-Ub interaction. The interaction with Ub was
 
specific, since, while mHDAC6 in the 
extract could efficiently
 
interact with GST-Ub (Fig. 4D, lane 1), no interaction was observed
 
between mHDAC6 and GST-SUMO1, a Ub-like protein (lane 2). We also
 
compared the 
ability of a fusion protein containing GST, Ub, and
 
the N-terminal tail of histone H4, with that 
of the same fusion
 
protein without the Ub part, to bind mHDAC6. Again, mHDAC6 was
 
efficiently retained on the fusion protein containing Ub (Fig.
 
4D, lane 4), whereas no 
interaction was observed with GST-H4 N-terminal
 
region (lane 3).  
 
 
The mHDAC6 C-terminal ZnF-UBP domain mediates the binding of Ub. 
 
  We then tried to identify the Ub-binding site of mHDAC6. Several deletion mutants 
of the protein were used to produce 
35
S-labeled proteins in vitro. Figure 5A shows that the C-
terminal
 
region of mHDAC6 is capable of efficient interaction with Ub (C-terminal
 
panel). In 
agreement with this observation, all mHDAC6 fragments
 
containing the C-terminal domain 
could also interact with Ub,
 
while no interaction was observed between mHDAC6 truncation 
mutants
 
lacking the C-terminal domain and Ub (Fig. 5A). In order to confirm
 
the direct 
involvement of the mHDAC6 ZnF-UBP domain in Ub binding,
 
histidines supposedly 
important in the formation of the zinc finger
 
(Fig. 3) were mutated. In the full-length protein, 
the replacement
 
of either one (m1 mutant) or two (m2 mutant) histidines drastically
 
affected 
the Ub-binding capacity of mHDAC6 (Fig. 5B, left panel).
 
The isolated 325-amino-acid C-
terminal region of HDAC6 has a strong
 
Ub binding activity (Fig. 5A, C-terminal panel, and 
5B, right
 
panel, wild type [WT]). The replacement of two histidines by alanines
 
was necessary 
to completely abolish the binding to Ub by this
 
fragment (Fig. 5B, m2 panel). 
 
This Ub-binding capacity of mHDAC6 was not shared with other HDACs, since two other 
members of the class II HDACs, mHDAC4
 
and mHDAC5, and one member of the class I 
HDACs, mHDAC1, did not
 
interact with Ub (Fig. 5C).  
mHDAC6 is one of the major Ub-binding proteins present in the mouse testis cytosolic 
extract. 
  In order to approach the complexity and the nature of the Ub-binding proteins in the 
mouse testis cytosolic extracts, a systematic
 
identification of Ub-binding proteins present in 
these extracts
 
was performed. Nine proteins efficiently interacting with Ub-agarose
 
were 
identified (Fig. 6). The binding of all of them to Ub-agarose
 
was severely affected by the 
addition of free Ub to the extracts
 
prior to the Ub-agarose pull-down experiment (Fig. 6, 
compare
 
Ub  and Ub+ lanes). Interestingly, three of these proteins were
 
members of Ub 
carboxy-terminal hydrolases (Ub carboxy-terminal
 
hydrolase 5, UCH-L3, and PGP9.5) and 
one, Ub carboxy-terminal
 
hydrolase 5, contained a ZnF-UBP. TIP120, a TATA-binding 
protein
 
(TBP)-interacting protein that appears to be involved in the activation
 
of transcription, 
was also found to be present in a complex containing
 
several proteasomal ATPases (24). Four 
proteins with unknown
 
function were also present in the pulled-down materials, AK011862,
 
AWP1, HSP C263, and AK006054. The first two contained a Ub-like
 
domain (not shown).  
 
Involvement of mHDAC6 in the control of protein ubiquitination. 
 
 Data obtained so far strongly suggest that mHDAC6 may have a role in protein 
ubiquitination. A direct approach to investigate
 
this issue would have been the use of an in 
vitro ubiquitination
 
system. However, such a system would have hardly allowed the study
 
of 
the role of mHDAC6 activity in protein ubiquitination. Indeed,
 
if using an extract, putative 
acetylated substrate proteins could
 
be nonspecifically deacetylated due to the presence of free 
and
 
active deacetylases. If use of a purified system containing E1,
 
E2 and E3 (see for instance, 
reference 22) had been chosen,
 
one would first have to find an acetylable substrate, find an
 
appropriate acetylase to acetylate it, and then evaluate the role
 
of mHDAC6 and its 
deacetylase activity in protein ubiquitination.
 
Considering all these difficulties, we chose to 
look at the influence
 
of the Ub-binding 325-amino-acid C-terminal domain of mHDAC6 on
 
in 
vitro protein ubiquitination. For this purpose, the histidine-tagged
 
C-terminal domain of 
mHDAC6 was expressed in bacteria, and the
 
purified protein was used to show its ability to 
directly bind
 
to Ub (Fig. 7A). We also showed that the mouse cytosolic extract
 
was very 
efficient to direct protein ubiquitination upon the addition
 
of ATP (Fig. 7B, compare lanes 
1 and 2). The addition of the increasing
 
amounts of mHDAC6 C-terminal domain interfered 
severely with protein
 
ubiquitination in the extract (lanes 3 and 4). This inhibiting
 
effect was 
relieved by the presence of free Ub (lane 10). These
 
data confirmed the ability of mHDAC6 to 
specifically interact
 
with Ub in the extract. They also showed that the interaction
 
between 
mHDAC6 C-terminal domain and Ub severely interfered with
 
the in vitro ubiquitination of 
proteins in the extract. In order
 
to confirm these results, recombinant proteins made of GST 
fused
 
to the C-terminal region of mHDAC6 either from the m2 mutant unable
 
to bind to Ub 
(Fig. 5B) or from the wild type protein were also
 
expressed in bacteria and purified.  
The influence of these recombinant proteins on in vitro protein ubiquitination was monitored 
as described above. Figure 7C
 
shows that, while the GST containing the wild-type C-terminal
 
region of mHDAC6 severely interfered with protein ubiquitination
 
(lanes 5 to 7), the mutated 
version of this protein unable to
 
bind to Ub did not affect protein ubiquitination in the extract
 
(lanes 2 to
 
4).  
We therefore suggested that mHDAC6 recruited by ubiquitinated proteins would have to be 
removed before the addition of other
 
Ub moieties and multi-Ub chain assembly. In agreement 
with this
 
hypothesis, we found that Ub binding led to the dissociation of
 
the mHDAC6-
containing complex. This implies that the mHDAC6-interacting
 
proteins present in the 
complex could play a role in dissociating
 
Ub-mHDAC6 (see
 
below).  
Ub binding dissociates the mHDAC6-containing complex. 
  Interestingly, the analysis of the proteins interacting with Ub in the testis cytosolic 
extract (Fig. 6) did not show the
 
presence of either p97/VCP/Cdc48 or PLAP. This 
observation suggests
 
either that the mHDAC6 fraction present in the complex does not
 
interact 
with Ub or that Ub binding dissociates the complex. In
 
order to investigate this issue, the testis 
cytosolic extract
 
was incubated with free Ub and mHDAC6 was immunoprecipitated with
 
the 
anti-mHDAC6 antibody. The immunoprecipitated materials were
 
then eluted with the 
immunogenic peptide and visualized on a silver-stained
 
SDS-PAGE gel. This experiment, 
performed at the same time as that
 
described in the legend to Fig. 2, showed that the 
coimmunoprecipitation
 
of p97/VCP/Cdc48 and PLAP was lost when free Ub had been added
 
to the extract (Fig. 8A, compare lanes  and +). In order to confirm
 
these findings, the 
immunoprecipitation of mHDAC6 was performed
 
under different conditions, and the presence 
of p97/VCP/Cdc48
 
and mHDAC6 was monitored with specific antibodies. Figure 8B shows
 
that, while p97/VCP/Cdc48p coimmunoprecipitated with mHDAC6 in
 
the absence of Ub (Fig. 
8B, lanes 1 and 2), p97/VCP/Cdc48p was
 
found in a very small amount in the 
immunoprecipitated material
 
from Ub-containing extracts (lanes 3 and 4). Since 
p97/VCP/Cdc48p
 
is an ATPase, we also tested the role of ATP in this dissociation
 
process and 
found that the release of p97/Cdc48p was independent
 
of ATP hydrolysis. Finally, we 
performed Ub pull-down assays with
 
Ub-agarose as described above and analyzed a fraction 
of Ub-bound
 
and unbound materials with anti-mHDAC6 and anti-p97/VCP/Cdc48p
 
antibodies. Figure 8C shows that, while almost all of the mHDAC6
 
present in the extract 
could be removed by using Ub-agarose beads,
 
all of the p97/VCP/Cdc48p was found in the 
unbound material (Fig.
 
8C, SN lane). No p97/VCP/Cdc48p was found in the bound materials
 
(lane P). 
 
Ub-bound mHDAC6 maintains its deacetylase activity. 
 
  Since Ub binding could modulate the nature of the mHDAC6 complex, we wanted to 
know whether mHDAC6, when recruited by ubiquitinated
 
proteins, would maintain its 
deacetylase activity and could therefore
 
deacetylate critical lysines on the ubiquitinated 
protein itself
 
or on other interacting proteins. The immunopurified mHDAC6 complex
 
(eluate 
from anti-mHDAC6 antibodies or peptide-blocked antibodies)
 
was used to deacetylate 
3
H-
labeled hyperacetylated histones. Autoradiography allows monitoring
 
of histone 
deacetylation, which results in the removal of the
 
radioactive label from histones. Figure 9 
shows that the binding
 
of Ub by mHDAC6 did not modify its deacetylase activity (compare
 
lanes 2 and 3), which remained trichostatin A (TSA) sensitive
 
(lane 6). In order to show the 
Ub-binding ability of this purified
 
mHDAC6 complex in these assays, the purified complex 
was incubated
 
with the Ub-agarose matrix, in the presence or absence of free
 
Ub, and 
centrifuged, and the supernatant was used to perform the
 
deacetylase assay (Ub-agarose SN). 
Our data showed that Ub-agarose
 
could deplete the deacetylase activity in the supernatant 
(lane
 
4) and that the presence of free Ub inhibited this depletion (lane
 
5). These experiments 
show that Ub can recruit active mHDAC6,
 
which suggests that ubiquitinated proteins would 
also recruit
 
the active deacetylase. Moreover, dissociation of Ub-bound mHDAC6
 
by histones 
during the reaction period was ruled out, since the
 
incubation of mHDAC6-containing Ub-
agarose beads with acetylated
 
histones during various times did not lead to the release of 
mHDAC6
 
(not shown).  
 
 
Discussion 
 Two lines of evidence suggest an involvement of mHDAC6 in the Ub-dependent 
signaling processes. First, two proteins copurified
 
with mHDAC6 showed striking sequence 
homology to yeast proteins
 
involved in Ub-dependent protein degradation. The first one, 
p97/VCP/Cdc48p,
 
an AAA-ATPase, was shown to participate in different functions,
 
depending on its partner proteins (29). Its role in Ub-dependent
 
protein degradation was first 
suggested in yeast, where it was
 
found in a complex with UFD3 (12) and then with E4/UFD2 
(22).
 
Moreover, p97/VCP/Cdc48p was recently shown to form a complex
 
with the mammalian 
homologue of yeast UFD1 (27). Finally, p97/VCP/Cdc48
 
was found to specifically associate 
with the ubiquitinated forms
 
of I B  and to probably control its proteasome-dependent 
degradation
 
(10). The second protein, PLAP, is a mammalian homologue of
 
yeast UFD3. 
PLAP is involved in the activation of several phospholipases
 
(30). In yeast, UFD3 seems to 
play a role in the control of
 
the concentration of free Ub in cells (19). Indeed, UFD3 mutants
 
have reduced levels of intracellular free Ub. The degradation
 
of the UFD substrates in these 
mutants could be restored by overexpressing
 
Ub. It is not clear how UFD3 may control the 
concentration of
 
cellular Ub in yeast. Since UFD3/PLAP is capable of activating
 
phospholipases, specifically phospholipase A2 (PLA2) (30), one
 
may expect the involvement 
of these enzymes in the control of
 
the free cellular Ub level. Interestingly, there is one hint in
 
the literature regarding the participation of PLA2 in the control
 
of Ub concentration. Indeed, it 
has been shown that a membrane-bound
 
form of Ub was associated with budded virions of 
baculovirus and
 
possessed a phospholipid anchor, which could be removed by PLA2
 
treatment 
(14). Therefore, PLA2 could release Ub from the membrane.
 
Although the massive presence 
of cellular Ub in a membrane-bound
 
form has not been evidenced, it is possible that 
PLAP/UFD3 participates
 
in the release of this putative pool through the activation of
 
PLA2. In 
the yeast UFD3 mutant, the absence of this PLAP-like
 
activity might be responsible for the 
observed decrease in the
 
amount of intracellular free
 
Ub.  
 The second line of evidence in favor of the involvement of mHDAC6 in protein 
ubiquitination relies on the analysis of the
 
structure of mHDAC6 itself. Indeed, a Ub 
carboxyl-terminal hydrolase-like
 
zinc finger (ZnF-UBP) domain was found in the C-terminal 
region
 
of mHDAC6. This particular domain with unknown function is shared
 
with a number 
of Ub-specific proteases (1). Here we showed
 
that this finger specifically mediated the 
interaction of mHDAC6
 
with Ub. Besides mHDAC6, we have also identified eight other Ub-
binding
 
proteins in the mouse testis cytosolic extract. Several are Ub
 
C-terminal hydrolases, 
which very probably directly interact with
 
Ub. One of them, the Ub carboxy-terminal 
hydrolase 5, also contained
 
a ZnF-UBP domain (not shown). Four noncharacterized proteins 
were
 
also on the list, and two of them showed a specific structural
 
motif suggesting a 
relationship with Ub signaling pathways. Indeed,
 
both AK011826 and AWPI possess a Ub-
like domain (not shown),
 
which is also found in several proteins containing a small region
 
of 
limited sequence identity to Ub (9).  
 Most interestingly, we also found TIP120 protein among the Ub-associated proteins. 
TIP120, a TBP-interacting protein, activates
 
the basal level of transcription from all three 
classes (I, II,
 
and III) of promoters (25). TIP120 is also part of a complex
 
containing several 
proteasomal ATPases (24). TIP120 is therefore
 
thought to participate in both transcriptional 
regulation and
 
proteasome-dependent protein degradation. Here we report a novel
 
property of 
TIP120: its ability to interact with
 
Ub.  
 In the literature, besides enzymes directly involved in protein ubiquitination, other 
proteins with Ub-binding activity have
 
been described. Indeed, several proteins involved in 
diverse functions
 
share a potential Ub-binding domain termed UBA. Two plant de novo
 
methyltransferases (7), as well as Rad23, involved in DNA repair
 
(32), and the mammalian 
protein, p62 (35), are among these
 
proteins. The UBA domain very probably links the activity 
of these
 
proteins to that of the Ub-dependent signaling pathway. Indeed,
 
the UBA domain was 
originally defined in various components of
 
the Ub-dependent protein degradation pathway, 
such as Ub C-terminal
 
hydrolases (UCHs), Ub-conjugating enzymes (E2), and Ub protein
 
ligases (E3) (16). In the case of Rad23, it has recently been
 
shown that UBA mediated the 
specific binding of Ub (5) and
 
that this interaction inhibited multi-Ub chain formation (28).  
 Here we found that the interaction of mHDAC6 with Ub led to the dissociation of the 
mHDAC6 complex and notably to the release
 
of p97/VCP/Cdc48. Interestingly, it has been 
reported that Ub
 
binding by yeast E4/UFD2 resulted in the release of Cdc48p (22).
 
Therefore, 
mHDAC6 shares three properties with the yeast E4/UFD2:
 
(i) Ub binding, (ii) interaction with 
p97/VCP/Cdc48, and (iii)
 
release of this partner after the interaction with Ub. However,
 
it is 
not clear how mHDAC6 participates in the control of protein
 
ubiquitination. Our data show 
that free Ub, and even a Ub sequence
 
inserted in the middle of a protein (GST-Ub-H4) (Fig. 
4), can
 
recruit mHDAC6. The latter suggests that once a protein is monoubiquitinated,
 
it 
becomes a potential target for mHDAC6. After the recruitment
 
of mHDAC6 by a 
monoubiquitinated protein, at least two scenarios
 
can be considered. First, mHDAC6 would 
deacetylate critical lysines
 
on the substrate protein (and/or partner proteins) and to allow
 
their 
ubiquitination. Indeed, the deacetylation of specific lysines
 
may allow their subsequent 
ubiquitination. Second, mHDAC6 would
 
control the activity of the ubiquitination machinery 
by deacetylating
 
them. Our in vitro assays suggested that the Ub-mHDAC6 complex
 
would 
have to be dissociated for the ubiquitination of substrate
 
proteins to take place. Since the Ub-
mHDAC6 interaction seems
 
to dissociate the mHDAC6-p97/VCP/Cdc48p complex, one may 
assume
 
that p97/VCP/Cdc48p could play a reverse role and would help mHDAC6
 
to release 
Ub. In agreement with this hypothesis, it has been
 
suggested that the basic activity of 
p97/VCP/Cdc48p would be protein
 
unfolding or disassembly of protein complexes (29).  
 Our experiments also suggest another property of mHDAC6. Indeed, the isolated C-
terminal domain of mHDAC6 seems to have a
 
better Ub-binding capacity than the full-length 
protein (Fig.
 
5A and B). This may suggest that the Ub-binding activity of mHDAC6
 
could be 
dependent on its conformation, which could itself be
 
controlled by posttranslational 
modifications or its interaction
 
with other partner
 
proteins.  
 Unfortunately, there is no hint in the literature about a possible mechanism linking 
protein acetylation to the Ub signaling
 
pathway. However, a relationship between protein 
acetylation and
 
stability has recently been demonstrated in the case of E2F, which
 
shows an 
increased half-life when acetylated (26). Our work
 
therefore strongly suggests a link between 
two key posttranslational
 
protein modifications acetylation and ubiquitination both 
modifying
 
lysine
 
residues.  
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FIG. 1.   mHDAC6 is overexpressed in mouse testis. (A) Extracts prepared from the indicated 
mouse tissues were used to obtain a Western blot, which was successively probed with anti-
HDAC6 and anti-HDAC1 antibodies. Fractions correspond to extracts prepared from 
spermatogenic cell populations enriched in the indicated cell types. P, pachytene; RS, round 
spermatids; RES, elongated and round spermatids. (B) Extracts from adult mouse testis 
(Testis) or from testis isolated from 6-day-old mice enriched in spermatogonia (Gonia), as 
well as cytoplasmic (C) and nuclear (N) extracts isolated from pachytene-enriched cells (P) 
were analyzed as in panel A. (C) A cryosection from adult mouse testis was used to 
immunodetect in situ mHDAC6 by using the anti-HDAC6 antibody (HDAC6 panel). The 
DNA panel shows corresponding Hoechst-labeled nuclei. 
  
 
 
FIG. 2.   p97/VCP/Cdc48p and PLAP are associated with mHDAC6. (A) Mouse testis 
cytoplasmic extracts were used to immunoprecipitate mHDAC6 with an anti-mHDAC6 
antibody (lane ) or the same antibody preincubated with its target peptide (lane +). Bound 
proteins were eluted and analyzed by SDS-PAGE and revealed after silver staining. The 
indicated bands were excised and identified by mass spectrometry (MALDI-TOF analysis and 
MS/MS). (B) The identity of mHDAC6 in the immunoprecipitates was confirmed by Western 
blotting.  
 
  
 
 
FIG. 3.   Homology between the mHDAC6 C-terminal domain and Ub-specific proteases 
(USPs). The sequence of the C-terminal region of mHDAC6 was aligned with that of several 
USPs from different species. Identical amino acids are boxed. The USP sequences are as 
follows: 1, human USP3, AF073344; 2, human USP20, AB023220; 3, Schizosaccharomyces 
pombe USP, AL021838; 4, Saccharomyces cerevisiae USP, P38237. Asterisks indicate 
histidines replaced by alanines described in a further experiment.  
 
  
 
 
FIG. 4.   mHDAC6 specifically interacts with Ub. (A) Mouse testis cytoplasmic extracts were 
incubated with an Ub-agarose matrix (lane 1). In control experiments, the indicated amounts 
of free Ub (lanes 2 to 4) or BSA (lanes 5 to 7) were added to the extract before the addition of 
the Ub-agarose. After the pull-down, bound proteins were eluted and analyzed by Western 
blotting with an anti-mHDAC6 antibody. (B and C) Ten microliters of supernatant after the 
pull-down (B) and the same amounts of the input materials (C) were used to monitor the 
presence of mHDAC6. (D) mHDAC6 interacts with Ub-fusion proteins, but not with the 
GST-SUMO-1 fusion. The pull-down was performed as described above with the 
immobilized indicated GST-fusion proteins. Bound proteins were analyzed as described 
above with an anti-mHDAC6 antibody. H4Nt, the N-terminal H4 histone tail.  
 
  
 
FIG. 5.   ZnF-UBP is the Ub-binding site of mHDAC6. (A) The indicated regions of 
mHDAC6 were cloned in an expression vector and used to generate 
35
S-labeled proteins in 
vitro. The pull-down was performed with Ub-agarose. (B) 
35
S-labeled mHDAC6 (full length 
or the C-terminal domain as indicated) bearing mutations in the ZnF-UBP (in m1, histidine 
1098 is replaced by alanine, and in m2, histidines 1094 and 1098 are replaced [Fig. 3]) was 
produced and used in a Ub-agarose pull-down assay as described above. (C) mHDAC1, 
mHDAC4, and mHDAC5 were labeled in vitro and used in Ub pull-down assays as described 
above.  
 
  
 
 
FIG. 6.   Identification of the major Ub-binding proteins present in mouse testis cytosolic 
extracts. (A) Proteins in mouse cytosolic testis extract retained on Ub-agarose beads were 
visualized on silver-stained SDS gel and compared with proteins retained on Ub-agarose 
beads when the pull-down was performed in the presence of an excess of free Ub (lane +). (B) 
The indicated bands were excised from a Coomassie blue-stained preparative SDS gel and 
identified by mass spectrometry as in Fig. 2. The table shows the identity of the excised 
bands. The right column shows the accession number and the corresponding database. 
  
 
 
FIG. 7.   Ub binding by mHDAC6 C-terminal region interferes with in vitro ubiquitination of 
proteins present in mouse testis cytosolic extract. (A) mHDAC6 binds directly to Ub. 
mHDAC6 C-terminal end (amino acids 824 to 1149) was cloned in an expression vector 
(pET-28a+; NOVAGEN). His-HDAC6 C-terminal region was produced and purified and 
used to perform Ub-agarose pull-down experiments in the absence ( ) or presence (+) of free 
Ub or BSA as indicated. After the pull-down, bound proteins were eluted and analyzed by 
Western blotting with an anti-mHDAC6 antibody. I, indicates 50% of the input material; lanes 
labeled Pull down show materials eluted after Ub-agarose pull-down. (B) Mouse testis 
cytosolic extract is capable of directing an in vitro ubiquitation of extract proteins in an ATP-
dependent manner. Cytosolic testis extracts were incubated in the absence ( ) or presence (+) 
of ATP and increasing amounts of the purified mHDAC6 C-terminal fragment (lanes 3 and 4) 
and the same number of molecules of BSA (lanes 5 and 6). After incubation, a fraction of the 
extract was used to monitor protein ubiquitination with a Western blot and an anti-Ub 
antibody (Santa Cruz). The right panel shows that the addition of free Ub relieves the 
mHDAC6 C-terminal-mediated repression of protein ubiquitination (compare lanes 9 and 10). 
(C) The C-terminal region of mHDAC6 (the same fragment described above) from the wild-
type protein or the m2 mutants (Fig. 3 and 5B) was fused to GST, expressed in bacteria, and 
purified (GST-Cter WT and GST-Cter m2, respectively). Increasing amounts of recombinant 
proteins were added to the extract as described above, and protein ubiquitination was 
monitored (upper panel). The lower panel shows the amount of GST-fusion proteins added to 
the extract in this experiment by analyzing a fraction of the samples with an anti-GST 
antibody. Lane 1 shows a standard ubiquitination reaction, and lane 8 shows the same reaction 
without ATP. 
  
 
 
FIG. 8.   Ub binding by mHDAC6 induces the release of p97/VCP/Cdc48p and PLAP. 
mHDAC6 from mouse cytosolic extracts was immunoprecipitated (IP)as described in the 
legend to Fig. 2 in the presence or absence of free Ub (+ and  lanes, respectively). 
Immunoprecipitated proteins were eluted with the immunogenic peptide and analyzed on a 
silver-stained gel. (This experiment was performed in parallel with that shown in Fig. 2A, and 
Fig. 2A and 8A are from the same gel.) The positions of mHDAC6, p97/VCP/Cdc48p, and 
PLAP are indicated. (B) Prior to immunoprecipitations of mHDAC6, the mouse testis extracts 
were preincubated with or without ATP (2 mM) and/or Ub as indicated. The presence of 
mHDAC6 and p97/VCP/Cdc48p in the immunoprecipitates was then determined by Western 
blotting with the corresponding antibodies. The input panel represents 2% of the amount of 
extract used in the immunoprecipitation. (C) Mouse cytosolic extracts were subjected to Ub 
pull-down with Ub-agarose beads as described in the legends to Fig. 4 and 6. Unbound 
materials present in the supernatant (SN) after the pull-down and bound materials retained on 
Ub-agarose beads (P) were used to monitor the presence of p97/VCP/Cdc48p and mHDAC6 
with the corresponding antibodies. 
  
 
 
FIG. 9.   Ub recruits an active mHDAC6. Twenty microliters of immunopurified mHDAC6 
(obtained as in Fig. 2) was incubated with 
3
H-labeled acetylated histones in the absence (lane 
2) or in the presence of free Ub (lane 3). Lane 6 shows the inhibition of the deacetylase 
activity of the Ub-bound mHDAC6 by 100 ng of TSA per ml. The reaction mixtures 
containing or not containing free Ub were incubated with Ub-agarose and centrifuged, and 
labeled histones were added to the supernatant (Ub-agarose SN) to measure the deacetylase 
activity (lanes 4 and 5, respectively). Lane 1 shows the input of labeled histones. (Lower 
panels) As controls, the same experiments as those described above were performed, except 
that eluates from peptide-blocked anti-mHDAC6, obtained as described in the legend to Fig. 
2, were analyzed.  
 
 
 
